Literature DB >> 12010319

Efficacy of 3-D computed tomographic reconstruction in evaluating anatomical relationships of colovesical fistula.

Toshiaki Shinojima1, Fumio Nakajima, Jun Koizumi.   

Abstract

A case of colovesical fistula is reported. The anatomy of the pelvis was determined preoperatively with 3-D computed tomography (CT), and the fistula, including adjacent structures, could clearly be seen. Compared with conventional axial CT imaging, 3-D CT provided better and more complete visualization of the anatomical relationships, which facilitated the surgical procedure and provided a good outcome.

Entities:  

Mesh:

Year:  2002        PMID: 12010319     DOI: 10.1046/j.1442-2042.2002.00451.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  5 in total

Review 1.  Enterovesical fistulas: diagnosis and management.

Authors:  G Scozzari; A Arezzo; M Morino
Journal:  Tech Coloproctol       Date:  2010-07-09       Impact factor: 3.781

2.  Delineating the anatomy of oncologic postradiation vesicovaginal fistulae with reconstructed computed tomography.

Authors:  Nathan Lawrentschuk; George Koulouris; Damien M Bolton
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-11-14

3.  Acute diarrhea and metabolic acidosis caused by tuberculous vesico-rectal fistula.

Authors:  Xiu-Qing Wei; Yan Zou; Zhi-E Wu; Kodjo-Kunale Abassa; Wei Mao; Jin Tao; Zhuang Kang; Zhuo-Fu Wen; Bin Wu
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

Review 4.  When the bowel meets the bladder: Optimal management of colorectal pathology with urological involvement.

Authors:  Conor Keady; Daniel Hechtl; Myles Joyce
Journal:  World J Gastrointest Surg       Date:  2020-05-27

Review 5.  Enterovesical fistulae: aetiology, imaging, and management.

Authors:  Tomasz Golabek; Anna Szymanska; Tomasz Szopinski; Jakub Bukowczan; Mariusz Furmanek; Jan Powroznik; Piotr Chlosta
Journal:  Gastroenterol Res Pract       Date:  2013-11-21       Impact factor: 2.260

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.